8,700 Studies Reviewed. 87.0% Found Biological Effects. The Evidence is Clear.
Shield Your Body
Brain & Nervous System184 citations

Effects of a hypomagnetic field on DNA methylation during the differentiation of embryonic stem cells

Bioeffects Seen

Baek S, Choi H, Park H, Cho B, Kim S, Kim J · 2019

Share:

An appropriate electromagnetic field environment appears necessary for normal epigenetic remodeling and successful cell differentiation in embryonic stem cells.

Plain English Summary

Summary written for general audiences

This study examined how hypomagnetic fields (HMFs) affect embryonic stem cell differentiation in rodents, focusing on epigenetic changes. The researchers found that HMF conditions impaired differentiation capacity and caused abnormal DNA methylation patterns by disrupting the expression of DNA methyltransferase3b (Dnmt3b), leading to incomplete methylation during cell fate determination.

Why This Matters

Hypomagnetic fields represent an unusual EMF exposure condition distinct from typical radiofrequency or power frequency exposures. The study's focus on epigenetic mechanisms (DNA methylation) rather than direct cellular damage provides a molecular-level perspective on potential EMF-related biological effects.

Exposure Information

Specific exposure levels were not quantified in this study.

Cite This Study
Baek S, Choi H, Park H, Cho B, Kim S, Kim J (2019). Effects of a hypomagnetic field on DNA methylation during the differentiation of embryonic stem cells.
Show BibTeX
@article{baek_s_choi_h_park_h_cho_b_kim_s_kim_j_ce3961,
  author = {Baek S and Choi H and Park H and Cho B and Kim S and Kim J},
  title = {Effects of a hypomagnetic field on DNA methylation during the differentiation of embryonic stem cells},
  year = {2019},
  doi = {10.1073/pnas.1819541116},
  
}
DOI: 10.1073/pnas.1819541116PubMed: 30718529

Quick Questions About This Study

NRF2 binds to specific DNA sequences in BACE1 gene promoters, directly suppressing production of the enzyme that creates toxic amyloid plaques. This natural regulatory mechanism helps prevent the accumulation of brain-damaging proteins that characterize Alzheimer's disease.
When researchers removed NRF2 from mouse brains, BACE1 enzyme levels increased, leading to more amyloid plaque production and worsened cognitive deficits. This demonstrates that NRF2 serves as a critical natural brake on Alzheimer's disease progression.
Yes, activating NRF2 in two different mouse models of Alzheimer's disease reduced both BACE1 enzyme production and toxic amyloid accumulation, while significantly improving cognitive performance and memory function in the animals.
BACE1-AS is an antisense RNA molecule that stabilizes BACE1 messenger RNA, effectively increasing BACE1 enzyme production. NRF2 suppresses both BACE1 and BACE1-AS transcription through the same antioxidant response element binding mechanism, providing dual protection against amyloid formation.
Since direct BACE1 enzyme inhibitors have failed in clinical trials due to side effects, targeting the transcriptional regulation of BACE1 through NRF2 activation offers a potentially safer therapeutic approach that works with natural cellular defense mechanisms.